drugset / Trial / NCT02012075
A Phase Ⅲ Study of Extended-Release Carvedilol Sulfate for the Treatment of Heart Failure
RandomizedParallel-groupDouble-blindTreatment
Summary
The aim of present study is to evaluate the efficacy and safety of Extended-Release Carvedilol Sulfate versus Sustained-release Metoprolol Succinate in Patients With Mild or Moderate Chronic Heart Failure.
Timeline
- Start
- 2013-12
- Primary completion
- 2015-02
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Carvedilol | Other / unclassified | 18 mg | Oral |
| Subject | Carvedilol | Other / unclassified | 72 mg | Oral |
| Comparator | Metoprolol | Other / unclassified | 11.875 mg | Oral |
| Comparator | Metoprolol | Other / unclassified | 190 mg | Oral |